Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 1, 2008, Pages 69-77

  Shima, Tatsuichiro ^a   Fukushima, Kouhei ^b   Setoyama, Hiromi ^a   Imaoka, Akemi ^a   Matsumoto, Satoshi ^a   Hara, Taeko ^a   Suda, Kazunori ^a   Umesaki, Yoshinori ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene expression; Indigenous bacteria; Mouse intestine; Probiotic

Indexed keywords

CHLORIDE CHANNEL; FUCOSYLTRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; PANCREATITIS ASSOCIATED PROTEIN; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BAGG ALBINO MOUSE; BIFIDOBACTERIUM BREVE; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GNOTOBIOTICS; ILEUM; IMMUNE FUNCTION TEST; INTESTINE EPITHELIUM; INTESTINE FLORA; LACTOBACILLUS CASEI; LIPID METABOLISM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BIFIDOBACTERIUM; COLON; COLONY COUNT, MICROBIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; ILEUM; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; LIPID METABOLISM; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROBIOTICS;

EID: 38149022737     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00344.x     Document Type: Article

References (22)

1. Bry L, Falk PG, Midtvedt T Gordon JI (1996) A model of host-microbial interactions in an open mammalian ecosystem. Science 273 : 1380 1383.
2. Cheng H Bjerknes M (1983) Cell production in mouse intestinal epithelium measured by stathmokinetic flow cytometry and Coulter particle counting. Anat Rec 207 : 427 434.
3. He W, Wang ML, Jiang HQ, Steppan CM, Shin ME, Thurnheer MC, Cebra JJ, Lazar MA Wu GD (2003) Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 125 : 1388 1397.
4. Hogan SP, Seidu L, Blanchard C et al 2006) Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 118 : 257 268.
5. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 : 881 884.
6. Lin DC (2003) Probiotics as functional foods. Nutr Clin Pract 18 : 497 506.
7. Matsumoto S, Setoyama H, Imaoka A, Okada Y, Amasaki H, Suzuki K Umesaki Y (1995) Gamma delta TCR-bearing intraepithelial lymphocytes regulate class II major histocompatibility complex molecule expression on the mouse small intestinal epithelium. Epithelial Cell Biol 4 : 163 170.
8. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A Sata M (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140 : 417 426.
9. Nagao F, Nakayama M, Muto T Okumura K (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64 : 2706 2708.
10. Ogawa H, Fukushima K, Sasaki I Matsuno S (2000) Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria. Am J Physiol Gastrointest Liver Physiol 279 : G492 G499.
11. Ohashi Y, Hiraguchi M Ushida K (2006) The composition of intestinal bacteria affects the level of luminal TgA. Biosci Biotechnol Biochem 70 : 3031 3035.
12. Qu XD, Lloyd KC, Walsh JH Lehrer RI (1996) Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 64 : 5161 5165.
13. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 : 1620 1633.
14. Spiller R (2005) Probiotics: an ideal anti-inflammatory treatment for IBS? Gastroenterology 128 : 783 785.
15. Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T Fagarasan S (2004) Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 101 : 1981 1986.
16. Szatmari I, Rajnavolgyi E Nagy L (2006) PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function. Ann N Y Acad Sci 1088 : 207 218.
17. Umesaki Y (1984) Immunohistochemical and biochemical demonstration of the change in glycolipid composition of the intestinal epithelial cell surface in mice in relation to epithelial cell differentiation and bacterial association. J Histochem Cytochem 32 : 299 304.
18. Umesaki Y (2000) Segmented filamentous bacteria as stimuli for the development of intestinal intraepithelial lymphocytes. Curr Trends Immunol 3 : 111 116.
19. Umesaki Y Setoyama H (2000) Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2 : 1343 1351.
20. Umesaki Y, Sakata T Yajima T (1982) Abrupt induction of GDP-fucose: asialo GM1 fucosyltransferase in the small intestine after conventionalization of germ-free mice. Biochem Biophys Res Commun 105 : 439 443.
21. Umesaki Y, Okada Y, Matsumoto S, Imaoka A Setoyama H (1995) Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol Immunol 39 : 555 562.
22. Umesaki Y, Setoyama H, Matsumoto S, Imaoka A Itoh K (1999) Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 67 : 3504 3511.